3-Amino-3-(3-chlorophenyl)propanoic acid finds application in the pharmaceutical industry as a key intermediate in the synthesis of various bioactive compounds. It is particularly utilized in the development of drugs targeting neurological disorders, such as anticonvulsants and antidepressants, due to its structural similarity to certain neurotransmitters. Additionally, it serves as a building block in the production of peptidomimetics, which are used in drug design to mimic the function of peptides. Its chlorophenyl group enhances binding affinity to specific receptors, making it valuable in medicinal chemistry research. The compound is also explored in the creation of novel therapeutic agents for treating chronic pain and inflammation.